Table 1.
Name | Taxa | Insights | Advantages | Limitations |
---|---|---|---|---|
Targeted genetic modifications | Established laboratory models (yeast, Drosophila, C. elegans, mice), wider range with recent development of CRISPR‐Cas (1) | Biochemical pathways and molecular targets for drug development (e.g., TOR and rapamycin (2)) | Opportunity to test the effects of single‐gene manipulations against a fixed genetic background | A fixed genetic background can have profound effects on the phenotypic outcome of a given intervention (3), but see also (4,5) for the use of diverse genetic background) |
Comparative genomics of long‐lived animals | Naked mole rats, bluefin whale and other long‐lived species | Genomic variations related to cellular mechanisms that facilitate protection against aging‐related declines (6) | Identification of shared genomic associations with long lifespan | Difficulty of disentangling longevity from other unusual species characteristics, such as eusociality or adaptation to subterranean life |
Cross‐sectional analyses of survival in wild populations | Mammals, birds, dragonflies | Specific challenges important to patterns of mortality under natural conditions (e.g., elevated risk of predation or bouts of mortality under particularly challenging environmental conditions) (7,8) | Clear identification of evolutionarily relevant sources of mortality and their timing, and estimates of gene‐by‐environment interactions | Low (if any) replication across populations, comparisons often made at the individual level within a single population (9,10) or between closely related species (8) |
Transcriptional and genetic association studies | Humans | Significant general association of APOE and FOXOA3 gene polymorphisms with long life (11); large population‐specificity in other aging‐related polymorphisms (12) | Large‐scale longitudinal data in replicated natural populations, often including details on functional declines | Insight into proximate mechanisms, but not directly into the evolution of aging |
Experimental evolution | Short‐lived laboratory animals (Callosobruchus, Caenorhabditis, Drosophila) | Demonstrating the capacity of specific organisms to respond to selection favoring increased or decreased rates of aging (13,14) | Maintains associated trade‐offs in other life‐history traits |
Commonly excludes tests of trade‐offs in response to challenging environment (but see (14)); lab‐adapted populations difficult to associate with natural settings; limited to short‐lived nonvertebrates |
Common garden experiments | Various taxa that can be kept in captivity | Revealing genetically‐determined interpopulation variation in aging traits | Standardization of environmental hazards; use of replicated natural populations | More complicated designs are needed to exclude population‐specific adaptations matching specific lab conditions (e.g., ambient temperature) |
References: (1) Harel et al. (2015); (2) López‐Otín et al. (2013); (3) Liao et al. (2010); (4) Harrison et al. (2009); (5) Lind et al. (2016); (6) Fang et al. (2014); (7) Hayward et al. (2011); (8) Wilson et al. (2007); (9) Massot et al. (2011); (10) Sharp and Clutton‐Brock (2011); (11) Deelen et al. (2011); (12) Beekman et al. (2013); (13) Stearns et al. (2000); (14) Chen and Maklakov (2012).